REM sleep disorder a risk factor for Parkinson's disease

Three-year study tracks dopamine levels in those who suffer behavioral sleep disorders.

August 17, 2011 13:25
1 minute read.
[illustrative photo]

Woman sleeping bed insomnia 311. (photo credit: Thinkstock/Imagebank)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Researchers have found that the progression of Parkinson’s disease can be detected in those who suffer from REM behavioral sleep disorders.

A three-part study published by Lancet Neurology and authored by doctors at Multidisciplinary Sleep Disorders Unit, is the third consecutive work in five years addressing the relationship between Rapid Eye Movement sleep disorder and Parkinson’s disease.

The first part of the study showed that 45 percent of patients who suffer this sleep disorder develop Parkinson’s disease and other neurodegenerative diseases caused by a lack of dopamine in the brain.

In Parkinson’s disease, for instance, a deficiency of dopamine in the substantia nigra causes tremor, stiffness and movement slowness in patients.

Using neuroimaging tests that measure dopamine levels on 20 patients with REM disorder and 20 healthy controls over three years, researchers concluded that dopamine in the brain decreases over the years in patients with REM sleep behavior disorder, which puts them at risk of developing a neurodegenerative disease such as Parkinson’s.

Authors of the study suggest that further development of neuroprotective drugs that prevent the dopamine concentration in at-risk patients and thus the progression of REM sleep behavior to Parkinson’s disease, are needed.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia